Congruent Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.74 Cr
- Revenue Growth 192.17%
- Profit Growth 111.85%
- Ebitda -11.26%
- Net Worth 149.99%
- Total Assets 35.60%
About Congruent Pharmachem
Congruent Pharmachem Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 April 2015 (Nine years and ten months 11 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.74 Cr.
Subhashchandra Motilal and Rohit Gupta serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2015PTC263554
- Company No.
263554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Congruent Pharmachem Private Limited offer?
Congruent Pharmachem Private Limited offers a wide range of products and services, including Immunization & Vaccination Drugs, Vaccines, Rabies Vaccine, Common Disease Medicines, Pharmaceutical Capsules, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Injectable Products, Anti Infective Drugs & Medicines, Favipiravir Tablet.
Who are the key members and board of directors at Congruent Pharmachem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Gupta  | Director | 31-Jan-2024 | Current |
| Subhashchandra Motilal | Director | 16-Apr-2015 | Current |
Financial Performance of Congruent Pharmachem.
Congruent Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 192.17% increase. The company also saw a substantial improvement in profitability, with a 111.85% increase in profit. The company's net worth Soared by an impressive increase of 149.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Congruent Pharmachem?
Unlock access to Congruent Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹17.40 M
₹0
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 1.74 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2024 | Standard Chartered Bank | ₹1.74 Cr | Open |
How Many Employees Work at Congruent Pharmachem?
Congruent Pharmachem has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Congruent Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Congruent Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
